Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
245.00    0.00 (0.00%)
Bid:
245.00
Ask:
250.00
Spread: 5.00 (2.041%)
Market Cap: £142.92m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Performance Share Plan award to Directors/PDMRs

12 Nov 2019 15:40

RNS Number : 1678T
MJ Gleeson PLC
12 November 2019
 

12 November 2019

 

MJ Gleeson plc ("Gleeson" or the "Company")

 

Performance Share Plan award to Directors/PDMRs

 

The Company announces that on 11 November 2019 Stefan Allanson, Chief Financial Officer, exercised share options ("Share Options") over 73,531 ordinary shares of 2 pence each in the capital of the Company ("Ordinary Shares") in connection with the Company's Long Term Incentive Plan ("LTIP").

 

Application has been made for the admission to trading of the new Ordinary Shares, which rank pari passu in all respects with the Company's existing Ordinary Shares, on the Main Market of the London Stock Exchange and to listing on the Official List of the UKLA, with dealings expected to commence on or around 15 November 2019.

 

Subsequent to the exercise and issue of the new Ordinary Shares, the Company has been notified that Stefan Allanson sold 34,663 Ordinary Shares at a price of £8.00 per Ordinary Share in order to satisfy tax liabilities resulting from the exercise of the above-mentioned options. Following the exercise and the sale, Stefan Allanson's shareholding has increased to 55,765 Ordinary Shares in the Company, representing 0.1 per cent. of the total voting rights in the Company.

 

Total Voting Rights

Following the issue of the new Ordinary Shares the total number of issued Ordinary Shares is 54,675,284. The Company does not hold any Ordinary Shares in Treasury.

 

Therefore, the total number of Ordinary Shares with voting rights is 54,675,284 which may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's DTR.

 

Enquiries:

MJ Gleeson plc Tel: 44 1142 612 900

James Thomson Interim Chief Executive Officer

Stefan Allanson Chief Financial Officer

 

Instinctif Partners Tel: 44 20 7457 2020

Mark Garraway

James Gray

 

N+1 Singer Tel: 44 20 7496 3000

Shaun Dobson

Rachel Hayes

 

Liberum Tel: 44 20 3100 2222

Neil Patel

Richard Bootle

 

The following notifications are intended to satisfy the Company's obligations under Article 19(3) of EU Regulation No 596/2014 (the Market Abuse Regulation).

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Stefan Allanson

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Financial Officer

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

MJ Gleeson plc

b)

 

LEI

 

21380064K7N2W7FD6434

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares of 2 pence each

 

 

GB00BRKD9Z53

b)

 

Nature of the transaction

 

 

Exercise of Share Options

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

Nil (exercise of options)

73,531

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

 

n/a

e)

 

Date of the transaction

 

 

11 November 2019

f)

 

Place of the transaction

 

 

Off market

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares of 2 pence each

 

 

GB00BRKD9Z53

b)

 

Nature of the transaction

 

 

Sale of Ordinary Shares

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

800p

34,663

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

 

n/a

e)

 

Date of the transaction

 

 

11 November 2019

f)

 

Place of the transaction

 

 

London Stock Exchange (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHCKBDNPBDDODD
Date   Source Headline
2nd Jun 20267:00 amRNSBoard Committee Changes
7th May 20264:36 pmRNSDirector/PDMR Shareholding
7th May 20262:49 pmRNSDirector/PDMR Shareholding
1st May 20267:00 amRNSTrading Update
23rd Apr 20267:00 amRNSNotice of Trading Updates and FY2026 Results
14th Apr 20269:34 amRNSDirector/PDMR Shareholding
14th Apr 20269:33 amRNSDirector/PDMR Shareholding
6th Mar 20263:19 pmRNSDirector/PDMR Shareholding
2nd Mar 20264:04 pmRNSHolding(s) in Company
11th Feb 20267:00 amRNSResults for the half year ended 31 December 2025
9th Feb 202610:47 amRNSDirector/PDMR Shareholding
9th Feb 20267:00 amRNS-RPresentation of HY Results on Engage Investor
16th Jan 20267:00 amRNSTrading Update and Notice of Results
6th Jan 20264:40 pmRNSDirector/PDMR Shareholding
9th Dec 202511:31 amRNSDirector/PDMR Shareholding
25th Nov 20251:01 pmRNSDirector/PDMR Shareholding
20th Nov 20253:25 pmRNSHolding(s) in Company
14th Nov 20252:46 pmRNSResult of AGM
14th Nov 20257:01 amRNSAppointment of Non-Executive Director
14th Nov 20257:00 amRNSAGM Trading Update
6th Nov 20255:09 pmRNSDirector/PDMR Shareholding
24th Oct 20254:16 pmRNSDirector/PDMR Shareholding
23rd Oct 20255:07 pmRNSDirector/PDMR Shareholding
20th Oct 20254:09 pmRNSDirector/PDMR Shareholding
17th Oct 20257:00 amRNSNotice of AGM
7th Oct 20253:18 pmRNSDirector/PDMR Shareholding
22nd Sep 20255:01 pmRNSREPLACEMENT: Director/PDMR Shareholding
18th Sep 20257:00 amRNS-RPresentation on Engage Investor Platform
17th Sep 20254:23 pmRNSDirector/PDMR Shareholding
16th Sep 20257:00 amRNSAudited results for the year ended 30 June 2025
9th Sep 202510:45 amRNSDirector/PDMR Shareholding
13th Aug 20257:00 amRNSNotice of Full-Year Results and Presentation
7th Aug 20253:05 pmRNSDirector/PDMR Shareholding
10th Jul 20254:17 pmRNSDirector/PDMR Shareholding
9th Jul 20251:05 pmRNSHolding(s) in Company
8th Jul 20254:00 pmRNSDirector/PDMR Shareholding
7th Jul 20253:11 pmRNSHolding(s) in Company
4th Jul 20257:00 amRNSDirectorate Change
4th Jul 20257:00 amRNSTrading Statement
12th Jun 20253:21 pmRNSDirector/PDMR Shareholding
10th Jun 202511:34 amRNSDirector/PDMR Shareholding
6th Jun 20257:00 amRNSHolding(s) in Company
4th Jun 20255:06 pmRNSDirector/PDMR Shareholding
3rd Jun 20257:03 amRNSTrading Update
7th May 20252:33 pmRNSDirector/PDMR Shareholding
24th Apr 20257:00 amRNSDirectorate Change
8th Apr 20255:22 pmRNSDirector/PDMR Shareholding
8th Apr 20255:17 pmRNSDirector/PDMR Shareholding
6th Mar 20254:52 pmRNSDirector/PDMR Shareholding
5th Mar 20252:54 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.